Jessica Shepherd
Gynecology · Dallas, TXNPI 1912160797
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by AbbVie at 45.9% of the total. Reporting peaked in 2019 at $216,851 and has fallen 89.3% since, to $23,187 in 2025. Among gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 800 payments — averaging $1011.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$371K
- Astellas Pharma US Inc$154K
- Acessa Health Inc.$65K
- Gen-probe, Inc.$54K
- Coopersurgical, Inc.$53K
- Pfizer$33K
- plus $80K from 22 others
Across 9 payments — averaging $2694.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$14K
- Astellas Pharma Global Development$10K
What the payments were for
- Consulting fees$270,49433%
- Speaking & faculty fees$429,19653%
- Travel & lodging$96,39612%
- Food & beverage$13,2902%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 423 | $371,243 |
| Astellas Pharma US Inc | 142 | $153,715 |
| Acessa Health Inc.(2 entities) | 91 | $64,904 |
| Gen-probe, Inc. | 18 | $54,071 |
| Coopersurgical, Inc. | 10 | $52,745 |
| Pfizer | 27 | $32,956 |
| Exeltis, USA Inc. | 3 | $22,900 |
| Myovant Sciences Inc. | 24 | $15,615 |
| Hologic Inc | 6 | $13,251 |
| Hologic Sales And Service, LLC | 17 | $11,552 |
| Astellas Pharma Global Development | 3 | $7,612 |
| Applied Medical Resources Corporation | 4 | $4,490 |
| UCB, Inc. | 1 | $2,500 |
| Asensus Surgical, Inc. | 4 | $569 |
| Scynexis, Inc. | 4 | $477 |
| Gynesonics, Inc. | 2 | $186 |
| Lupin Inc. | 3 | $147 |
| Focal Therapeutics, Inc. | 1 | $126 |
| Teleflex LLC | 1 | $90 |
| Therapeuticsmd, Inc. | 5 | $62 |
| Johnson & Johnson | 2 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $27 |
| Duchesnay USA Incorporated | 2 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| Minerva Surgical, Inc | 1 | $20 |
| Millicent US Inc | 1 | $16 |
| Avanos Medical | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$247,555
- ORIAHNN$125,793
- Veozah$123,375
- Paragard$52,500
- ACESSA PROVU SYSTEM$37,455
- Acessa$27,783
- NONE$26,300
- Slynd$22,900
- MYFEMBREE$15,454
- NURTEC ODT$12,052
- Myosure$9,960
- NovaSure$8,437
- GELPOINT$4,476
- ALEXIS CONTAINED EXTRACTION SYSTEM$4,476
- GELPORT$3,266
- THINPREP 2000 PROCESSOR$3,000
- Aptima$3,000
- ABRYSVO$1,750
- DUAVEE$1,294
- ZAVZPRET$717
How this compares
$809,377 in reported general payments places this provider in the 95th percentile of 161 gynecology providers in Texas.
Other gynecology in Dallas
- Stephanie ChangDallas$4K
- Steven HarrisDallas$3K
- Shadae BealeDallas$3K
- Angela WalkerDallas$3K
- Glen HeckmanDallas$2K
- Richard FarnamEl Paso$1.2M
- Linda LacyEl Paso$627K
- John WhitfieldFort Worth$141K
- Robert ZurawinHouston$61K
- Charles EubankCorpus Christi$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.